Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-02-02 @ 7:42 AM
Study NCT ID:
NCT00879359
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2009-04-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Sponsor:
Organization: